Can tenecteplase (TNKase) be administered through a central venous catheter when peripheral intravenous access is unavailable?

Can Tenecteplase Be Administered Through a Central Line?

Yes, tenecteplase can be administered through a central venous catheter when peripheral access is unavailable, though the FDA label specifies "intravenous administration" without restricting the route to peripheral veins only. 1

Administration Route Guidance

The FDA-approved prescribing information for tenecteplase states that it is "for intravenous (IV) administration only, administered as a single bolus over 5 seconds" but does not explicitly prohibit central venous administration. 1 The key requirement is that the medication reaches the central circulation rapidly as a bolus.

Practical Considerations for Central Line Use

When both central and peripheral access are available, medications that are more effective when administered closer to the heart (such as adenosine) should be given centrally. 2 However, for tenecteplase specifically:

• The drug must be delivered as a single rapid bolus over 5 seconds, regardless of access route 1
• Central venous catheters, particularly multilumen catheters, have increased resistance due to their length, which can make rapid bolus administration more challenging compared to peripheral access 2
• The bolus must be followed by a saline flush to ensure complete drug delivery into the central circulation 1

Clinical Context

In emergency situations where peripheral access cannot be rapidly established:

• Central venous access is not recommended as the initial route during emergencies due to the time required for placement 2
• Intraosseous (IO) access is preferred over attempting central line placement in cardiac arrest or critically ill patients when peripheral access fails, as all intravenous medications can be administered via IO route with comparable onset and drug levels 2
• If a central line is already in place (e.g., in hospitalized patients), it is acceptable to use for tenecteplase administration

Critical Administration Requirements

Regardless of whether peripheral or central access is used:

1. Flush dextrose-containing lines with 0.9% sodium chloride before and after tenecteplase, as the drug is incompatible with dextrose and precipitation will occur 1
2. Administer as a single bolus over 5 seconds using sterile technique by connecting the syringe directly to the IV port 1
3. Use weight-based dosing: 30 mg for <60 kg, 35 mg for 60-69 kg, 40 mg for 70-79 kg, 45 mg for 80-89 kg, and 50 mg for ≥90 kg 1

Common Pitfalls to Avoid

• Do not dilute tenecteplase for infusion—it must be given as a rapid bolus 3
• Do not delay administration to place a central line if peripheral or IO access is available 2
• Ensure the line is flushed properly before and after administration, especially if dextrose solutions were previously running 1
• Verify the line is patent and functioning before bolus administration to avoid extravasation or incomplete delivery